This page was last updated: December 3rd, 2021
Roz Davies, General Manager for Sustainability at the Royal Cornwall Hospital, says, “Our patient’s won’t experience any difference in their care, it’s simply the processing of the exhaled gas that is different, as the state-of-the-art technology renders the gases harmless. The MDU not only tackles the effects of climate change but improves safety for our staff by further reducing the risk of breathing in escaped nitrous oxide.”
The first patients to use the MDU in Endoscopy are from the Bowel Cancer Screening Programme; a precautionary screening programme which identifies the early stages of cancer and has been estimated to prevent up to 60% of bowel cancer.
Dr John Beckly, Consultant Gastroenterologist, said, “It seemed only fitting the screening programme, a first of its kind, when it launched was matched by another trailblazing solution. This time, not only keeping our patients safe but also protecting our environment, and ultimately the health of our population.”
Jonas Lundh, Chief Executive of Medclair adds, “The significance of the Bowel Cancer Screening programme is hard to overstate. That we can now demonstrate a method ensuring minimal environmental impact with no discomfort to patients is a real success. We feel this a major advance in green use of nitrous oxide, and we are delighted to support the healthcare system in the UK with our key mission: providing sustainable solutions wherever N2O is used.”
